Don’t take anti-innovation, activist funded academics at their word
PhRMA
OCTOBER 18, 2022
It’s disappointing to see yet more studies published by activist-funded industry critics that fail to recognize the nature of competition in the biopharmaceutical market and use cherry-picked data to draw misleading conclusions.
Let's personalize your content